Johnson & Johnson shares are down 3% Wednesday on safety concerns that could dim sales prospects for a new heart device, while its rivals gained. J&J said it temporarily paused the use of the heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback